← Leaderboards
Elizabeth M McNally
University Of Chicago
$39,500,544
Attributed
$53,766,852
Total exposure
37
Grants
27
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$60,354,666 · 39
By mechanism
R01$30,320,944 · 10
U01$10,645,633 · 3
P01$8,287,334 · 3
T32$5,123,110 · 2
UG3$2,060,218 · 1
U54$1,065,599 · 2
Top collaborators
- Marcelo A. Nobrega11 shared
- Alexis R. Demonbreun10 shared
- Rex L Chisholm7 shared
- Laura J Rasmussen-Torvik7 shared
- Alfred L George4 shared
- Jonathan C Makielski4 shared
- Igor R Efimov2 shared
- John Rogers2 shared
Most similar at University Of Chicago
Same institution · by research overlap
- M Eileen Dolan$15,055,139
- Marcelo A. Nobrega$13,690,128
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesGeneticMuscular DystrophiesProteinsMuscleMutationPathway InteractionsMyopathyComplexMediatingDystrophinMembraneIn VivoCardiomyopathiesCardiacResearch PersonnelCellsDefectLinkGene MutationNatural RegenerationFibrosisResponseHeart
Grant awards (154)
Extracellular matrix regulation of cellular crosstalk in cardiac fibrosis$706,992
R01 · FY2025 · HL · contact PI
Extension of Northwestern Genomic Risk Assessment and Management Program$702,803
U01 · FY2025 · HG
Project 2 - McNally (NU)_Spencer (UCLA)$538,643
P50 · FY2025 · HD · contact PI
Development of anti-LTBP4 as a biologic to treat Limb Girdle Muscular Dystrophy 2C$440,000
R21 · FY2025 · TR
Mechanisms of resealing and rebuilding in muscle repair$400,000
R01 · FY2025 · NS · contact PI
Northwestern Genomic Risk Assessment and Management Program$711,809
U01 · FY2024 · HG
Extracellular matrix regulation of cellular crosstalk in cardiac fibrosis$692,853
R01 · FY2024 · HL · contact PI
Transforming health at the intersection of implementation science, learning health systems, and genomics at Northwestern Medicine$666,062
U01 · FY2024 · HG
Development of anti-LTBP4 as a biologic to treat Neuromuscular Diseases$616,017
UH3 · FY2024 · NS
Optimization of electromechanical monitoring of engineered heart tissues$457,365
R33 · FY2024 · HL · contact PI
Mechanisms of resealing and rebuilding in muscle repair$388,000
R01 · FY2024 · NS · contact PI
Northwestern Genomic Risk Assessment and Management Program$1,128,645
U01 · FY2023 · HG
Extracellular matrix regulation of cellular crosstalk in cardiac fibrosis$706,992
R01 · FY2023 · HL · contact PI
Cardiomyopathy Genomes Project$575,272
R01 · FY2023 · HL · contact PI
Development of anti-LTBP4 as a biologic to treat Neuromuscular Diseases$565,309
UG3 · FY2023 · NS
Optimization of electromechanical monitoring of engineered heart tissues$466,698
R33 · FY2023 · HL · contact PI
Mechanisms of resealing and rebuilding in muscle repair$400,000
R01 · FY2023 · NS · contact PI
Development of anti-LTBP4 as a biologic to treat Neuromuscular Diseases$1,494,909
UG3 · FY2022 · NS
Northwestern Genomic Risk Assessment and Management Program$1,315,764
U01 · FY2022 · HG
Cardiomyopathy Genomes Project$575,272
R01 · FY2022 · HL · contact PI
Sarcoglycan in Myopathy and Muscle Membrane Stability$395,000
R01 · FY2022 · HL · contact PI
Myoferlin in muscle membrane fusion and repair$345,625
R01 · FY2022 · NS · contact PI
Bridging Basic and Translational Science in Cardiovascular Disease$30,000
R13 · FY2022 · HL · contact PI
Northwestern Genomic Risk Assessment and Management Program$1,334,634
U01 · FY2021 · HG
Cardiomyopathy Genomes Project$598,176
R01 · FY2021 · HL · contact PI
Regulating fibrosis and growth through latent TGFbeta binding proteins$395,000
R01 · FY2021 · HL · contact PI
Sarcoglycan in Myopathy and Muscle Membrane Stability$395,000
R01 · FY2021 · HL · contact PI
Myoferlin in muscle membrane fusion and repair$345,625
R01 · FY2021 · NS · contact PI
Northwestern University Molecular and Translational Cardiovascular Training Program$334,969
T32 · FY2021 · HL · contact PI
Cardiomyopathy Genomes Project$37,741
R01 · FY2021 · HL · contact PI
New Frontiers in Cardiovascular Research and Therapy$24,000
R13 · FY2021 · HL · contact PI
New Directions in Biology and Disease of Skeletal Muscle$10,000
R13 · FY2021 · AR · contact PI
Northwestern Genomic Risk Assessment and Management Program$1,072,225
U01 · FY2020 · HG
Cardiomyopathy Genomes Project$650,303
R01 · FY2020 · HL · contact PI
Failed Regeneration in the Muscular Dystrophies: Inflammation, Fibrosis and Fat - Administrative Supplement$403,938
U54 · FY2020 · AR
Regulating fibrosis and growth through latent TGFbeta binding proteins$395,000
R01 · FY2020 · HL · contact PI
Sarcoglycan in Myopathy and Muscle Membrane Stability$395,000
R01 · FY2020 · HL · contact PI
Northwestern Genomic Risk Assessment and Management Program$384,018
U01 · FY2020 · HG
Northwestern University Molecular and Translational Cardiovascular Training Program$378,929
T32 · FY2020 · HL · contact PI
Myoferlin in muscle membrane fusion and repair$345,625
R01 · FY2020 · NS · contact PI
New Directions in Biology and Disease of Skeletal Muscle$15,000
R13 · FY2020 · AR · contact PI
Channelopathies and Cardiomyopathies Among Sudden Deaths in the Young$829,012
U01 · FY2019 · HL
Cardiomyopathy Genomes Project$589,772
R01 · FY2019 · HL · contact PI
Regulating fibrosis and growth through latent TGFbeta binding proteins$395,000
R01 · FY2019 · HL · contact PI
Sarcoglycan in Myopathy and Muscle Membrane Stability$395,000
R01 · FY2019 · HL · contact PI
Northwestern University Molecular and Translational Cardiovascular Training Program$361,856
T32 · FY2019 · HL · contact PI
Myoferlin in muscle membrane fusion and repair$345,625
R01 · FY2019 · NS · contact PI
Cardiomyopathy Genomes Project$52,127
R01 · FY2019 · HL · contact PI
Channelopathies and Cardiomyopathies Among Sudden Deaths in the Young$829,012
U01 · FY2018 · HL
Mechanisms of sulfonylurea receptor mediated cardiomyopathy$588,488
R01 · FY2018 · HL · contact PI
Cardiomyopathy Genomes Project$535,868
R01 · FY2018 · HL · contact PI
Regulating fibrosis and growth through latent TGFbeta binding proteins$395,000
R01 · FY2018 · HL · contact PI
Sarcoglycan in Myopathy and Muscle Membrane Stability$383,599
R01 · FY2018 · HL · contact PI
Northwestern University Molecular and Translational Cardiovascular Training Program$349,682
T32 · FY2018 · HL · contact PI
Myoferlin in muscle membrane fusion and repair$345,625
R01 · FY2018 · NS · contact PI
New Directions in Biology and Disease of Skeletal Muscle$25,000
R13 · FY2018 · NS · contact PI
Channelopathies and Cardiomyopathies Among Sudden Deaths in the Young$829,012
U01 · FY2017 · HL
Mechanisms of sulfonylurea receptor mediated cardiomyopathy$600,788
R01 · FY2017 · HL · contact PI
Cardiomyopathy Genomes Project$535,868
R01 · FY2017 · HL · contact PI
Sarcoglycan in Myopathy and Muscle Membrane Stability$380,630
R01 · FY2017 · HL · contact PI
Channelopathies and Cardiomyopathies Among Sudden Deaths in the Young$842,637
U01 · FY2016 · HL
Mechanisms of sulfonylurea receptor mediated cardiomyopathy$616,178
R01 · FY2016 · HL · contact PI
Cardiomyopathy Genomes Project$543,593
R01 · FY2016 · HL · contact PI
Sarcoglycan in Myopathy and Muscle Membrane Stability$377,749
R01 · FY2016 · HL · contact PI
Myoferlin in muscle membrane fusion and repair$337,969
R01 · FY2016 · NS · contact PI
New Directions in Biology and Disease of Skeletal Muscle$25,000
R13 · FY2016 · NS · contact PI
Regulating fibrosis and muscle growth in the muscular dystrophies$1,228,986
P01 · FY2015 · NS · contact PI
Mechanisms of sulfonylurea receptor mediated cardiomyopathy$637,499
R01 · FY2015 · HL · contact PI
Cardiomyopathy Genomes Project$557,218
R01 · FY2015 · HL · contact PI
Myoferlin in muscle membrane fusion and repair$337,969
R01 · FY2015 · NS · contact PI
LTBPS as Regulators of TGF(beta) and Myostatin$289,590
P01 · FY2015 · NS · contact PI
Adminstrative Core$67,331
P01 · FY2015 · NS · contact PI
Regulating fibrosis and muscle growth in the muscular dystrophies$1,141,818
P01 · FY2014 · NS · contact PI
Sarcoglycan in Myopathy and Muscle Membrane Stability$338,268
R01 · FY2014 · HL · contact PI
Myoferlin in muscle membrane fusion and repair$319,723
R01 · FY2014 · NS · contact PI
LTBPS as Regulators of TGF(beta) and Myostatin$290,290
P01 · FY2014 · NS · contact PI
LTBPS as Regulators of TGF(beta) and Myostatin$256,171
P01 · FY2014 · NS · contact PI
Mapping Modifiers of Cardiomyopathy un Muscular Dystrophy$166,280
U54 · FY2014 · AR · contact PI
Regulating fibrosis and muscle growth in the muscular dystrophies$85,935
P01 · FY2014 · NS · contact PI
Adminstrative Core$67,494
P01 · FY2014 · NS · contact PI
Adminstrative Core$59,410
P01 · FY2014 · NS · contact PI
Sarcoglycan in Myopathy and Muscle Membrane Stability$45,179
R01 · FY2014 · HL · contact PI
New Directions in Biology and Disease of Skeletal Muscle$30,000
R13 · FY2014 · NS · contact PI
Myoferlin in muscle membrane fusion and repair$22,447
R01 · FY2014 · NS · contact PI
Regulating fibrosis and muscle growth in the muscular dystrophies$1,207,666
P01 · FY2013 · NS · contact PI
Sarcoglycan in myopathy and muscle membrane stability$367,567
R01 · FY2013 · HL · contact PI
Myoferlin in muscle membrane fusion and repair$333,529
R01 · FY2013 · NS · contact PI
Cardiovascular Sciences Training Grant$314,853
T32 · FY2013 · HL · contact PI
LTBPS as Regulators of TGF(beta) and Myostatin$286,515
P01 · FY2013 · NS · contact PI
Adminstrative Core$66,616
P01 · FY2013 · NS · contact PI
Mapping Modifiers of Cardiomyopathy un Muscular Dystrophy$32,026
U54 · FY2013 · AR · contact PI
Regulating fibrosis and muscle growth in the muscular dystrophies$1,262,940
P01 · FY2012 · NS · contact PI
Sarcoglycan in myopathy and muscle membrane stability$386,100
R01 · FY2012 · HL · contact PI
Myoferlin in muscle membrane fusion and repair$345,625
R01 · FY2012 · NS · contact PI
Cardiovascular Sciences Training Grant$317,804
T32 · FY2012 · HL · contact PI
LTBPS as Regulators of TGF(beta) and Myostatin$300,647
P01 · FY2012 · NS · contact PI
Mapping Modifiers of Cardiomyopathy un Muscular Dystrophy$154,664
U54 · FY2012 · AR · contact PI
Adminstrative Core$69,903
P01 · FY2012 · NS · contact PI
New Directions in Biology and Disease of Skeletal Muscle$32,500
R13 · FY2012 · NS · contact PI
Regulating fibrosis and muscle growth in the muscular dystrophies$1,256,531
P01 · FY2011 · NS · contact PI
Sarcoglycan in myopathy and muscle membrane stability$390,000
R01 · FY2011 · HL · contact PI
Cardiovascular Sciences Training Grant$385,910
T32 · FY2011 · HL · contact PI
Nuclear membrane protein interaction in heart and muscle disease$384,624
R01 · FY2011 · HL · contact PI
LTBPS as Regulators of TGF(beta) and Myostatin$285,139
P01 · FY2011 · NS · contact PI
Mapping Modifiers of Cardiomyopathy un Muscular Dystrophy$99,969
U54 · FY2011 · AR · contact PI
Adminstrative Core$64,352
P01 · FY2011 · NS · contact PI
Sarcoglycan in myopathy and muscle membrane stability$390,000
R01 · FY2010 · HL · contact PI
Myoferlin in muscle membrane fusion and repair$390,000
R01 · FY2010 · NS · contact PI
Nuclear membrane protein interaction in heart and muscle disease$384,624
R01 · FY2010 · HL · contact PI
Cardiovascular Sciences Training Grant$354,145
T32 · FY2010 · HL · contact PI
Mapping Modifiers of Cardiomyopathy un Muscular Dystrophy$208,722
U54 · FY2010 · AR · contact PI
New Directions in Biology and Disease of Skeletal Muscle$40,000
R13 · FY2010 · NS · contact PI
Myoferlin in muscle membrane fusion and repair$390,000
R01 · FY2009 · NS · contact PI
Sarcoglycan in myopathy and muscle membrane stability$390,000
R01 · FY2009 · HL · contact PI
Nuclear membrane protein interaction in heart and muscle disease$384,624
R01 · FY2009 · HL · contact PI
Sulfonylurea KATP channels in vascular spasm$356,715
R01 · FY2009 · HL · contact PI
Cardiovascular Sciences Training Grant$200,814
T32 · FY2009 · HL · contact PI
Sarcoglycan in myopathy and muscle membrane stability$23,475
R01 · FY2009 · HL · contact PI
Cardiovascular Sciences Training Grant$466,711
T32 · FY2008 · HL · contact PI
Nuclear membrane protein interaction in heart and muscle disease$384,624
R01 · FY2008 · HL · contact PI
Sulfonylurea KATP channels in vascular spasm$356,715
R01 · FY2008 · HL · contact PI
New Directions in Biology and Disease of Skeletal Muscle$40,000
R13 · FY2008 · NS · contact PI
Cardiovascular Sciences Training Grant$466,711
T32 · FY2007 · HL · contact PI
Sulfonylurea KATP channels in vascular spasm$356,715
R01 · FY2007 · HL · contact PI
Sarcoglycan in Myopathy and Muscle Membrane Stability$334,044
R01 · FY2007 · HL · contact PI
GENETICS OF CARDIAC DISEASE$1,124
M01 · FY2007 · RR · contact PI
Cardiovascular Sciences Training Grant$466,711
T32 · FY2006 · HL · contact PI
Sulfonylurea KATP channels in vascular spasm$367,369
R01 · FY2006 · HL · contact PI
Myoferlin in Muscle Membrane Fusion and Repair$349,001
R01 · FY2006 · NS · contact PI
Sarcoglycan in Myopathy and Muscle Membrane Stability$334,500
R01 · FY2006 · HL · contact PI
New Directions in Biology and Disease of Skeletal Muscle$40,000
R13 · FY2006 · NS · contact PI
GENETIC STUDIES OF CARDIOVASCULAR DISORDERS$701
M01 · FY2006 · RR · contact PI
Sulfonylurea KATP channels in vascular spasm$376,210
R01 · FY2005 · HL
Myoferlin in Muscle Membrane Fusion and Repair$357,400
R01 · FY2005 · NS
Sarcoglycan in Myopathy and Muscle Membrane Stability$333,077
R01 · FY2005 · HL
Cardiovascular Sciences Training Grant$262,007
T32 · FY2005 · HL
Conference on Molecular Biology of Cardiac Diseases$10,000
R13 · FY2005 · HL
GENETIC STUDIES OF CARDIOVASCULAR DISORDERS$4,471
M01 · FY2005 · RR
Cardiovascular Sciences Training Grant$462,007
T32 · FY2004 · HL
Myoferlin in Muscle Membrane Fusion and Repair$357,400
R01 · FY2004 · NS
Sarcoglycan in Myopathy and Muscle Membrane Stability$323,884
R01 · FY2004 · HL
GENE EXPRESSION IN LIMB GIRDLE MUSCULAR DYSTROPHY$159,444
R01 · FY2004 · AR
Genetic Studies of Cardiovascular Disorders$5,309
M01 · FY2004 · RR
Myoferlin in Muscle Membrane Fusion and Repair$357,400
R01 · FY2003 · NS
SARCOGLYCAN IN MYOPATHY AND MUSCLE MEMBRANE STABILITY$291,543
R01 · FY2003 · HL
GENETICS STUDIES OF FAMILIAL DILATED CARDIOMYOPATHY$247,411
R01 · FY2003 · HL
GENE EXPRESSION IN LIMB GIRDLE MUSCULAR DYSTROPHY$172,175
R01 · FY2003 · AR
CARDIOVASCULAR SCIENCES TRAINING GRANT$1
T32 · FY2003 · HL
SARCOGLYCAN IN MYOPATHY AND MUSCLE MEMBRANE STABILITY$283,053
R01 · FY2002 · HL
GENETICS STUDIES OF FAMILIAL DILATED CARDIOMYOPATHY$240,204
R01 · FY2002 · HL
SARCOGLYCAN IN MYOPATHY AND MUSCLE MEMBRANE STABILITY$274,808
R01 · FY2001 · HL
GENETICS STUDIES OF FAMILIAL DILATED CARDIOMYOPATHY$233,208
R01 · FY2001 · HL
SARCOGLYCAN IN MYOPATHY AND MUSCLE MEMBRANE STABILITY$266,803
R01 · FY2000 · HL
GENETICS STUDIES OF FAMILIAL DILATED CARDIOMYOPATHY$226,415
R01 · FY2000 · HL